If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

Share Price is delayed by 15 minutes
Get Live Data
0.10    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.02 (22.222%)
Market Cap: £1.48m
GUN Live PriceLast checked at - London Stock Exchange

Intraday Gunsynd Share Chart

Sunshine Minerals Update

4 Apr 2017 16:17

RNS Number : 5763B
Gunsynd PLC
04 April 2017
 

Gunsynd plc ("Gunsynd" or the "Company")

 

Sunshine Minerals Update

 

Gunsynd Plc (AIM: GUN, NEX: GUN) is pleased to announce an update in respect of Sunshine Minerals Ltd ("Sunshine"), a company in which it holds a 10% interest. Sunshine has now received a land user agreement for its Tausere bauxite deposit licence. The Tausere bauxite deposit is a non resource defined early stage exploration asset over a 510km² tenement area with 3 target areas. Historical assay results show average bauxite geochemistry of 42% and a possible total inferred resource (resource for which there is insufficient data to confirm its continuity) in the prospecting licence area of 288,228,000 tons.

Hamish Harris, the Company's Executive Chairman, commented:

"We are very pleased that Sunshine has been able to obtain a land user agreement that was required in conjunction with the prospecting licence it has already acquired. Sunshine is now in a position to commence validating the resource. We also expect to hear back shortly with respect to the Jejevo licence for which a land user agreement is already in place"

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

The directors of Gunsynd accept responsibility for this announcement.

 

For further information please contact:

 

Gunsynd plc

+44 (0) 20 7440 0640

Hamish Harris

 

Nominated Adviser/NEX Exchange Corporate Adviser

+44 (0) 20 7213 0880

Cairn Financial Advisers LLP

James Caithie / Liam Murray

 

Peterhouse Corporate Finance (Joint Broker)

+44 (0)20 7469 0930

Lucy Williams

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEZLFBDZFFBBZ
Date   Source Headline
30th Sep 20117:00 amRNSBusiness Update
27th Sep 20117:00 amRNSPosting of Circular and Notice of General Meeting
8th Jul 20117:00 amRNSChange of Registered Office
21st Jun 201111:00 amRNSDirectorate Change
23rd May 201111:45 amRNSResult of General Meeting
11th May 201111:17 amRNSDirector's Dealing
6th May 20117:00 amRNSAcquisition and Placing to raise £2 million
27th Apr 20112:30 pmRNSBusiness Update
8th Mar 20117:00 amRNSInterim Results
2nd Mar 20113:12 pmRNSHolding(s) in Company
25th Feb 20117:00 amRNSHolding(s) in Company
20th Jan 20111:23 pmRNSResult of AGM
17th Jan 20117:00 amRNSSyntopix to research biofilms for Beiersdorf AG
14th Jan 201110:13 amRNSPosting of Annual Report and notice of AGM
3rd Dec 20107:00 amRNSGrant of share options to Directors
29th Nov 20107:00 amRNSFinal Results
11th Nov 20107:00 amRNSAppointment of Broker
1st Nov 20107:00 amRNSSecond Agreement with Sinclair Pharma
29th Sep 20105:05 pmRNSHolding(s) in Company
27th Sep 20102:51 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSAgreement with Global Consumer Products Company
22nd Jun 20103:20 pmRNSDirectorate Change
22nd Apr 20107:00 amRNSAgreement with Sinclair Pharma plc
31st Mar 201011:25 amRNSResult of General Meeting
15th Mar 201011:08 amRNSProposed Fundraising
12th Mar 20107:00 amRNSInterim Results
3rd Feb 20107:00 amRNSDirectorate Change
2nd Feb 20102:30 pmRNSResult of AGM
7th Jan 20107:00 amRNSPreliminary results
12th Nov 20097:00 amRNSBusiness Update
12th Nov 20097:00 amRNSClinical results from Phase II cosmetic study
28th Apr 20097:00 amRNSHalf Yearly Report
14th Apr 20097:00 amRNSRe Contract
3rd Nov 20087:00 amRNSFinal Results
25th Sep 20087:00 amRNSChange of Adviser
29th Aug 20087:00 amRNSTotal Voting Rights
12th Aug 200811:58 amRNSHolding(s) in Company
6th Aug 20081:13 pmRNSResult of EGM & Director's In
15th Jul 20087:00 amRNSProposed fundraising
3rd Jul 20087:00 amRNSProctor & Gamble Agreement
24th Apr 20087:00 amRNSInterim Results
25th Feb 20087:00 amRNSPositive Trial Results
4th Feb 200810:51 amRNSHolding(s) in Company
21st Dec 20072:50 pmRNSOral Healthcare Agreement
15th Nov 20074:03 pmRNSAnnual Report and Accounts
18th Oct 20077:01 amRNSPreliminary Results
16th Aug 20077:00 amRNSPhase I Results
13th Jun 20077:01 amRNSPhase I Acne Trial Starts
8th May 20077:02 amRNSCRO Appointment
30th Apr 20079:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.